Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a quieter, automated blood pressure check help more people control hypertension?

NCT ID NCT07822022

Disease control Sponsor: Menzies Institute for Medical Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers are testing whether a standardized automated blood pressure measurement protocol in Australian general practice clinics improves hypertension control among adults. The protocol uses a validated device that takes several readings automatically after a five-minute rest, with patients seated quietly. The trial compares hypertension control rates before and after clinics adopt the protocol, and also looks at whether clinics can integrate and sustain the approach in routine care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Automated office blood pressure measurement, a standardized protocol where a validated device takes several readings automatically after a quiet rest period
What this could lead to
If it works, this could give general practices a practical way to measure blood pressure more accurately and help more patients reach guideline targets for hypertension control.
What could go wrong
This is an implementation trial, not a test of a new drug, so results depend on whether busy clinics can adopt the protocol consistently. Better measurement may not translate into better blood pressure control if follow-up treatment does not change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 6,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Oct 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients will be eligible to participate if they meet Australian guideline-recommended criteria for BP measurement, either for absolute CVD risk assessment or for BP assessment as an individual risk factor, and are attending a participating general practice clinic during the study period. Eligible participants include: Adults attending participating general practice clinics who are eligible for BP measurement for absolute CVD risk assessment, including: * Adults aged 45 to 79 years without known CVD * Adults aged 35 to 79 years with diabetes and without known CVD * First Nations peoples aged 30 to 79 years without known CVD Adults eligible for BP assessment as an individual risk factor, including: * First Nations peoples aged 18 to 29 years * Adults aged 18 years and over where BP measurement is clinically indicated based on individual risk factors or clinical judgement (e.g. suspected hypertension from BP measurements outside the clinic, obesity, abnormal cholesterol levels, secondary causes of hypertension, or time elapsed since last BP measurement) Exclusion Criteria: * Patients who are unable to provide informed consent. * Patients whose participation is deemed clinically inappropriate by the treating general practitioner.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases (CVD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder hypertensive disorder vascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular diseases (CVD) Hypertension Vascular diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Menzies Institute for Medical Research, University of Tasmania

    Hobart, Tasmania, 7000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.